Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Vennerstrom

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|April 10, 2007
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloproteaseJames C Burnett, Dejan Opsenica, Kamaraj Sriraghavan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
The comparative antimalarial properties of weak base and neutral synthetic ozonidesYuanqing Tang, Sergio Wittlin, Susan A Charman, et al.
Journal of Medicinal Chemistry|July 22, 2005
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypesYuxiang Dong, Jacques Chollet, Hugues Matile, et al.
Bioorganic & Medicinal Chemistry|June 9, 2006
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanesYuxiang Dong, Yuanqing Tang, Jacques Chollet, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Nature|August 20, 2004
Identification of an antimalarial synthetic trioxolane drug development candidateJonathan L Vennerstrom, Sarah Arbe-Barnes, Reto Brun, et al.
ACS Infectious Diseases|June 8, 2021
Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439David M Shackleford, Francis C K Chiu, Kasiram Katneni, et al.
Journal of Medicinal Chemistry|November 21, 2009
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan, et al.
ACS Infectious Diseases|October 18, 2024
Single-Dose Drug Development Candidate for SchistosomiasisDerek A Leas, Jennifer Keiser, Susan A Charman, et al.
ACS Omega|April 22, 2022
Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12)Yuxiang Dong, Yogesh Sonawane, Steven P Maher, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|April 10, 2007
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloproteaseJames C Burnett, Dejan Opsenica, Kamaraj Sriraghavan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
The comparative antimalarial properties of weak base and neutral synthetic ozonidesYuanqing Tang, Sergio Wittlin, Susan A Charman, et al.
Journal of Medicinal Chemistry|July 22, 2005
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypesYuxiang Dong, Jacques Chollet, Hugues Matile, et al.
Bioorganic & Medicinal Chemistry|June 9, 2006
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanesYuxiang Dong, Yuanqing Tang, Jacques Chollet, et al.
ACS Infectious Diseases|April 3, 2020
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67Abdulraman M Alshammari, D David Smith, Jake Parriott, et al.
Nature|August 20, 2004
Identification of an antimalarial synthetic trioxolane drug development candidateJonathan L Vennerstrom, Sarah Arbe-Barnes, Reto Brun, et al.
ACS Infectious Diseases|June 8, 2021
Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439David M Shackleford, Francis C K Chiu, Kasiram Katneni, et al.
Journal of Medicinal Chemistry|November 21, 2009
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan, et al.
ACS Infectious Diseases|October 18, 2024
Single-Dose Drug Development Candidate for SchistosomiasisDerek A Leas, Jennifer Keiser, Susan A Charman, et al.
ACS Omega|April 22, 2022
Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12)Yuxiang Dong, Yogesh Sonawane, Steven P Maher, et al.
Pageof 11